Our services

More than a deal advisor, we’re your growth partner.

Get Started Now

Jarlen Capital combines scientific depth, transaction experience, and cross-border networks to support BioPharma innovators and investors. We clarify where your assets fit, build and run BD motions, structure licensing deals, and support commercialization and access strategy so you can move with confidence from discovery to patients.

Asset & partnering strategy

We clarify asset positioning and partnering strategy so the right global counterparties see the value fast.

Asset & partnering strategy

We clarify asset positioning and partnering strategy so the right global counterparties see the value fast.

Asset & partnering strategy

We clarify asset positioning and partnering strategy so the right global counterparties see the value fast.

BD pipeline & outreach

We design and run targeted BD campaigns, qualifying and progressing conversations from first intro to term sheet.

BD pipeline & outreach

We design and run targeted BD campaigns, qualifying and progressing conversations from first intro to term sheet.

BD pipeline & outreach

We design and run targeted BD campaigns, qualifying and progressing conversations from first intro to term sheet.

Licensing & deal structuring

We build licensing constructs and economics that balance risk, upside, and strategic control.

Licensing & deal structuring

We build licensing constructs and economics that balance risk, upside, and strategic control.

Licensing & deal structuring

We build licensing constructs and economics that balance risk, upside, and strategic control.

Commercialisation

We map priority markets, routes-to-market, and launch partners to accelerate adoption and revenue.

Commercialisation

We map priority markets, routes-to-market, and launch partners to accelerate adoption and revenue.

Commercialisation

We map priority markets, routes-to-market, and launch partners to accelerate adoption and revenue.

Strategic insights

We connect clinical, regulatory, and competitive insight into practical choices on where, when, and how to partner.

Strategic insights

We connect clinical, regulatory, and competitive insight into practical choices on where, when, and how to partner.

Strategic insights

We connect clinical, regulatory, and competitive insight into practical choices on where, when, and how to partner.

Execution excellence

We manage cross-border negotiations, workstreams, and governance so signed deals translate into performance.

Execution excellence

We manage cross-border negotiations, workstreams, and governance so signed deals translate into performance.

Execution excellence

We manage cross-border negotiations, workstreams, and governance so signed deals translate into performance.

Risk and compliance

We assess and mitigate risks ahead of time to secure essential assets and credibility.

Risk and compliance

We assess and mitigate risks ahead of time to secure essential assets and credibility.

Risk and compliance

We assess and mitigate risks ahead of time to secure essential assets and credibility.

Your questions, our expert answers

Get Expert Consultation

01. At what stage of development does it make sense to work with Jarlen Capital?

02. Do you only work with biotech companies, or also with pharma and investors?

03. How do you typically engage, project-based, ongoing support, or as an extended BD function?

04. How is your work different from what a bank, broker, or generic consulting firm would do?

At what stage of development does it make sense to work with Jarlen Capital?

Do you only work with biotech companies, or also with pharma and investors?

How do you typically engage, project-based, ongoing support, or as an extended BD function?

How is your work different from what a bank, broker, or generic consulting firm would do?

01. At what stage of development does it make sense to work with Jarlen Capital?

02. Do you only work with biotech companies, or also with pharma and investors?

03. How do you typically engage, project-based, ongoing support, or as an extended BD function?

04. How is your work different from what a bank, broker, or generic consulting firm would do?

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.